Potential of Ginkgo biloba L. leaves in the management of hyperglycemia and hypertension using in vitro models

Bioresource Technology

Volumn 100, Issue 24, 2009, Pages 6599-6609

  Da Silva Pinto, Marcia ^a   Kwon, Young In ^b   Apostolidis, Emmanouil ^b   Lajolo, Franco Maria ^a   Genovese, Maria Inés ^a   Shetty, Kalidas ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Antioxidant activity; Diabetes; Ginkgo biloba L.; Hypertension; Phenolics

Indexed keywords

ANTIOXIDANT ACTIVITY; DIABETES; GINKGO BILOBA L.; HYPERTENSION; PHENOLICS;

ENZYMES; ETHANOL; SOLVENT EXTRACTION; WATER CONTENT;

PHENOLS;

ALCOHOL; ALPHA GLUCOSIDASE; AMYLASE; DIPEPTIDYL CARBOXYPEPTIDASE; GINKGO BILOBA EXTRACT; WATER;

ANTIOXIDANT; DIABETES; ENZYME; ETHANOL; HYPERTENSION; INHIBITION; LEAF; NUMERICAL MODEL; PHENOL; SEASONAL VARIATION; TREE;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ISOLATION; ENZYME INHIBITION; HYPERGLYCEMIA; HYPERTENSION; IN VITRO STUDY; PLANT LEAF; PRIORITY JOURNAL; SEASONAL VARIATION; SOLVENT EXTRACTION;

ALPHA-AMYLASES; ALPHA-GLUCOSIDASES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIOXIDANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GINKGO BILOBA; HYPERGLYCEMIA; HYPERTENSION; KAEMPFEROLS; MODELS, BIOLOGICAL; PEPTIDYL-DIPEPTIDASE A; PHENOLS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; QUERCETIN; RABBITS; SEASONS;

GINKGO BILOBA;

EID: 69249220318     PISSN: 09608524     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biortech.2009.07.021     Document Type: Article

References (65)

1. Ali H., Houghton P.J., and Soumyanath A. α-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. Journal of Ethnopharmacology 107 (2006) 449-455
2. Amaral J.S., Seabra R.M., Andrade P.B., Valentao P., Pereira J.A., and Ferreres F. Phenolic profile in the quality control of walnut (Juglans regia L.) leaves. Food Chemistry 88 (2004) 373-379
3. Bailey, C.J., 2003. New approaches to the pharmacotherapy of diabetes. In: Pickup, J.C., William, G. (Eds.), Textbook of Diabetes, vol. 2, third ed. Blackwell Science Ltd., UK, pp. 73.1-73.21.
4. Bhandari M.R., Jong-Anurakkun N., Hong G., and Kawabata J. α-Glucosidase and α-amylase inhibitory activities of Nepalese medicinal herb Pakhanbhed (Bergenia ciliata, Haw). Food Chemistry 106 (2008) 247-252
5. Bilia A.R. Ginkgo biloba L. Fitoterapia 73 (2002) 276-279
6. Blumenthal M. Herb sales down 15 percent in mainstream market. Herbalgram 51 (2001) 69
7. Braquet, P., Koltai, M., 1994. Vasculoprotective effect of the platelet-activating factor antagonist ginkgolide B isolated from Ginkgo biloba leaves. In: Clostre, F., De Feudis, F.V. (Eds.), Advances in Ginkgo biloba Extract Research. Cardiovascular Effect of Ginkgo biloba Extract (EGb 761), vol. 3. Elsevier, Paris, France.
8. Brevoort P. The booming US botanical market - a new overview. Herbalgram 44 (1998) 33-46
9. Broadhurst C.L. Nutrition and non-insulin dependent diabetes from an anthropological perspective. Alternative Medicine Review 2 (1997) 378-399
10. Carlson J.J., Farquhar J.W., Dinucci E., Ausserer L., Zehnder J., Miller D., Berra K., Hagerty L., and Haskell W.L. Safety and efficacy of a Ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. Journal of the American Dietetic Association 107 (2007) 422-432
11. Chung K.F., McCuster M., Page C.P., Dent G., Guinot P.H., and Barnes P.J. Effect of a ginkgolide mixture (BN 52063) in antagonizing skin and platelet responses to platelet activating factor in man. Lancet 31 (1987) 248-251
12. Diamond B.J., Shiflett S.C., Feiwel N., Matheis R.J., Noskin O., Richard J.A., and Schoenberger N.E. Ginkgo biloba extract: mechanisms and clinical indications. Archives of Physical Medicine and Rehabilitation 81 (2000) 668-678
13. Duarte J., Pérez-Palencia R., Vargas F., Ocete M.A., Pérez-Vizcaino F., Zarzuelo A., and Tamargo J. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. British Journal of Pharmacology 133 (2001) 117-124
14. Ellnain-Wojtaszek M., and Zgórka G. High-performance liquid chromatography and thin-layer chromatography of phenolic acids from Ginkgo biloba L. leaves collected within vegetative period. Journal of Liquid Chromatography & Related Technologies 22 (1999) 1457-1471
15. Ellnain-Wojtaszek M., Kruczyński Z., and Kasprzak J. Analysis of the content of flavonoids, phenolic acids as well as free radicals from Ginkgo biloba L. leaves during the vegetative cycle. Acta Poloniae Pharmaceutica 58 3 (2001) 205-209
16. Ellnain-Wojtaszek M., Kruczynski Z., and Kasprzak J. Variations in the free radical scavenging activity of Ginkgo biloba L. leaves in the period of complete development of green leaves to fall of yellow ones. Food Chemistry 79 (2002) 79-84
17. Ellnain-Wojtaszek M., Kruczynski Z., and Kasprzak J. Investigation of the free radical scavenging activity of Ginkgo biloba L. leaves. Fitoterapia 17 (2003) 1-6
18. Ferrandini, C., Sekaki, A., Droy-Lefaix, M.T., 1993. Oxygen-centered free radicals and their interactions with EGb 761 or CP 202. In: Ferradini, C., Droy-Lefaix, M.T., Christen, Y. (Eds.), Advances in Ginkgo biloba Extract Research. Ginkgo biloba extract (EGb 761) as a free radical scavenger, vol. 2. Elsevier, Paris, France.
19. Gao H., Huang Y.N., Xu P.Y., and Kawabata J. Inhibitory effect on α-glucosidase by the fruits of Terminalia chebula Retz. Food Chemistry 105 (2007) 628-634
20. Goh L.M., and Barlow P.J. Flavonoid recovery and stability from Ginkgo biloba subjected to a simulated digestion process. Food Chemistry 86 (2004) 195-202
21. Goh L.M., Barlow P.J., and Yong C.S. Examination of antioxidant activity of Ginkgo biloba leaf infusions. Food Chemistry 82 (2003) 275-282
22. Gouda K.G.M., Gowda L.R., Rao A.G.A., and Prakash V. Angiotensin-I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). Journal of Agricultural and Food Chemistry 54 (2006) 4568-4573
23. Hibatallah J., Carduner C., and Poelman M.C. In-vivo and in-vitro assessment of the free-radical-scavenger activity of Ginkgo flavone glycosides at high concentration. The Journal of Pharmacy and Pharmacology 51 12 (1999) 1435-1440
24. Hu F.B. The role of diet and lifestyle modifications in the statin era. Journal of the American Dietetic Association (2005) 1718-1721
25. Ibarra M., Moreno L., and Vera R. Effects of the flavonoid quercetin and its methylated metabolite isorhamnetin in isolated arteries from spontaneously hypertensive rats. Planta Medica 69 (2003) 995-1000
26. Iwaoka, W.T., Brewer, M.S., 2000. Toxicants. In: Christen, G.L., Smith, J.S., (Eds.), Food Chemistry: Principles and Application Chapter 15, Science Technology System, West Sacramento, California, pp. 241-260.
27. Jacobs B.P., and Browner W.S. Ginkgo biloba: a living fossil. The American Journal of Medicine 108 (2000) 341-342
28. Johnston J.I., and Franz V. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. Journal of Hypertension 10 (1992) 13-26
29. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., and He J. Global burden of hypertension: analysis of worldwide data. The Lancet 365 9455 (2005) 217-223
30. Khan A., Bryden N.A., Polansky M.M., and Anderson R.A. Insulin potentiating factor and chromium content of selected foods and spices. Biological Trace Element Research 24 (1990) 183-188
31. Kotowaroo M.I., Mahomoodally M.F., Gurib-Fakim A., and Subratty A.H. Screening of traditional antidiabetic medicinal plants of Mauritius for possible α-amylase inhibitory effects in vitro. Phytotherapy Research 20 (2006) 228-231
32. Kubota Y., Tanaka N., Kagota S., Nakamura K., Kunitomo M., Umegaki K., and Shinozuka K. Effects of Ginkgo biloba extract feeding on salt-induced hypertensive Dahl rats. Biological and Pharmaceutical Bulletin 29 (2006) 266-269
33. Kudolo G.B. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic β-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus. Journal of Clinical Pharmacology 41 (2001) 600-611
34. Kudolo G.B., Dorsey S., and Blodgett J. Effect of ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and type 2 diabetic subjects. Thrombosis Research 108 (2002) 151-160
35. Kudolo G.B., Delaney D., and Blodgett J. Short-term oral ingestion of Ginkgo biloba extract (EGb 761) reduces malondialdehyde levels in washed platelets of type 2 diabetic subjects. Diabetes Research and Clinical Practice 68 (2005) 29-38
36. Kwon Y.I., Vattem D.V., and Shetty K. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pacific Journal of Clinical Nutrition 15 (2006) 107-118
37. Lee J., Bae I.Y., Lee H.G., and Yang C. Tyr-Pro-Lys, an angiotensin-I-converting enzyme inhibitory peptide derived from broccoli (Brassica oleracea Italica). Food Chemistry 99 (2006) 143-148
38. Lock K., Pomerleau J., Causer L., Altmann D.R., and McKee M. The global burden of disease attributable to low consumption of fruit and vegetables: implications for the global strategy on diet. Bulletin of the World Health Organization: The International Journal of Public Health 83 2 (2005) 100-108
39. Manach C., Williamson G., Morand C., Scalbert A., and Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. American Journal of Clinical Nutrition 81 (2005) 230-242
40. Matsui T., Ueda T., Oki T., Sugita K., Terahara N., and Matsumoto K. α-Glucosidase inhibitory action of natural acylated anthocyanins. I. Survey of natural pigment with potent inhibitory activity. Journal of Agricultural and Food Chemistry 49 (2001) 1948-1951
41. McCue P., Kwon Y.I., and Shetty K. Anti-amylase, anti-glucosidase and anti-angiotensin I-converting enzyme potential of selected foods. Journal of Food Biotechnology 29 (2005) 278-294
42. McDougall G.J., Shpiro F., Doboson P., Smith P., Black A., and Stewart D. Different polyphenolic compounds of soft fruits inhibit α-amylase and α-glucosidase. Journal of Agricultural and Food Chemistry 53 (2005) 2760-2766
43. Negishi H., Xu J.W., Ikeda K., Njelekela M., Nara Y., and Yamori Y. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. Journal of Nutrition 134 (2004) 38-42
44. Pietri S., Maurelli E., Drieu K., and Culcasi M. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba (EGB 761). Journal of Molecular and Cellular Cardiology 29 (1997) 733-742
45. Pietta P.G., Gardana C., Mauri P.L., Maffei-Facino R., and Carini M. Identification of flavonoid metabolites after oral administration to rats of a Ginkgo biloba extract. Journal of Chromatography B (1995) 75-80
46. Puls W., Keup U., Krause H., Thomas P.G., and Hoffmeister F. Glucosidase inhibition: a new approach to the treatment of diabetes, obesity, and hyperlipoproteinemia. Naturwissen Schaften 64 (1977) 536-537
47. Rababah T.M., Hettiarachchy N.S., and Horax R. Total phenolics and antioxidant activities of fenugreek, green tea, black tea, grape seed, ginger, rosemary, Gotu kola, and Ginkgo extracts, vitamin E, and tert-butylhydroquinone. Journal of Agricultural and Food Chemistry 52 (2004) 5183-5186
48. Ramassamy C., Christen Y., Clostre F., and Costentin J. The Ginkgo biloba extract EGb 761, increases synaptosomal uptake of 5-hydroxy tryptamine: in vitro and ex vivo studies. Journal of Pharmacy and Pharmacology 44 (1992) 943-945
49. Rudge M.V.C., Damasceno D.C., Volpato G.T., Almeida F.C.G., Calderon I.M.P., and Lemonica I.P. Effect of Ginkgo biloba on the reproductive outcome and oxidative stress biomarkers of streptozotocin-induced diabetic rats. Brazilian Journal of Medical and Biological Research 40 (2007) 1095-1099
50. Shahidi F., and Marian N. Phenolics in Food and Nutraceuticals vol. 1 (2003), CRC Press, Boca Raton, FL pp. 144-150
51. Shetty, K., Curtis, O.F., Levin, R.E., Wikowsky, R., Ang, W., 1995. Prevention of verification associated with in vitro shoot culture of oregano (Origanum vulgare) by Pseudomonas spp. Journal of Plant Physiology 147, 447-451.
52. Tada Y., Kagota S., Kubota Y., Nejime N., Nakamura K., Kunitomo M., and Shinozura K. Long-term feeding of Ginkgo biloba extract impairs peripheral circulation and hepatic function in aged spontaneously hypertensive rats. Biological and Pharmaceutical Bulletin 31 (2008) 68-72
53. Tenney L. Ginkgo biloba (1996), Woodland Publishing, Pleasant Grove, UT
54. Toor R.K., Savage G.P., and Lister C.E. Seasonal variations in the antioxidant composition of greenhouse grown tomatoes. Journal of Food Composition and Analysis 19 (2006) 1-10
55. Uchida S., Yamada H., Li X.D., Maruyama S., Ohmori Y., Oki T., Watanabe H., Umegaki K., Ohashi K., and Yamada S. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers. Journal of Clinical Pharmacology 46 (2006) 1290-1298
56. Wang M., Lamers R.J.A.N., Korthout H.A.A.J., Van Nesselrooij J.H.J., Witkamp R.F., Van der Heijden R., Voshol P.J., Havekes L.M., Verpoorte R., and Van der Greef J. Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytotherapy Research 19 (2005) 173-182
57. Welt K., Weiss J., Martin R., Hermsdorf T., Drews S., and Fitzl G. Ginkgo biloba extract protects rat kidney from diabetic and hypoxic damage. Phytomedicine 14 (2007) 196-203
58. White H.L., Scates P.W., and Cooper B.R. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Science 58 (1996) 1315-1321
59. Willet W.C. Balancing life-style and genomics research for disease prevention. Science 296 (2002) 695-698
60. Alpha amylase. In: Worthington V. (Ed). Worthington Enzyme Manual (1993), Worthington Biochemical Corp., Freehold, NJ 36-41
61. Maltase-α-glucosidase. In: Worthington V. (Ed). Worthington Enzyme Manual (1993), Worthington Biochemical Corp., Freehold, NJ p. 261
62. Wu Y., Li S., Cui W., Zu X., Du J., and Wang F. Ginkgo biloba extract improves coronary blood flow in healthy elderly adults: role of endothelium-dependent vasodilation. Phytomedicine 15 (2008) 164-169
63. Ye B., Aponte M., Dai Y., Li L., Ho M.C.D., Vitonis A., Edwards D., Huang T.N., and Cramer D.W. Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence. Cancer Letters 251 (2007) 43-52
64. Yeh G.Y., Davis R.B., and Phillips R.S. Use of complementary therapies in patients with cardiovascular disease. The American Journal of Cardiology 98 5 (2006) 673-680
65. Zuess J. Ginkgo the Smart Herb (1998), Three River Press, New York